financetom
Business
financetom
/
Business
/
TripAdvisor Is Down Over 30% After Q1 Results - What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TripAdvisor Is Down Over 30% After Q1 Results - What's Going On?
May 8, 2024 6:41 AM

TripAdvisor, Inc. ( TRIP ) shares are falling in the premarket session on Wednesday.

The company reported first-quarter adjusted earnings per share of 12 cents, beating the street view of 2 cents. 

Quarterly revenues of $395 million marginally beat the analyst consensus of $394.86 million, increasing 6% year over year. 

Total Adjusted EBITDA in the quarter under review jumped 42% to $47 million.

Brand Tripadvisor sales slumped 2% year over year to $240 million. Adjusted EBITDA margin for Brand Tripadvisor expanded to 33% from 30% in the year-ago period. The improvement in adjusted EBITDA margin was largely driven by lower selling and marketing and lower people costs as a percent of revenue.

Viator revenue was $141 million, reflecting year-over-year growth of 23%.  

The company bore the brunt of hefty adjustments, resulting in an income tax expense of $42 million for the first quarter of 2024.

In addition, accepting the Mutual Agreement Procedure settlement for income taxes for multiple years, TripAdvisor ( TRIP ) sees an estimated net operating cash outflow of $110 million to $120 million, inclusive of related interest expense, which is expected to be substantially settled by the company during the second quarter of 2024. 

Chances Of Transaction Ceased!

In February 2024, TripAdvisor ( TRIP ) disclosed that it had formed a special committee to evaluate proposals resulting from Liberty Tripadvisor Holdings’ stated intention to engage in discussions with respect to a potential transaction or other alternatives. 

The Special Committee now said it sees no transaction with a third party. However, it will continue to evaluate proposed alternatives as appropriate.

“We are pleased with our first quarter results, which provide a solid start to the fiscal year, and were driven by the continued diversification of our portfolio into higher growth experiences offerings,” said Chief Executive Officer Matt Goldberg. 

Price Action: TRIP shares are trading lower by 31.8% to $17.40 premarket at last check Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Myers Industries Names Samantha Rutty as CFO
Myers Industries Names Samantha Rutty as CFO
Sep 5, 2025
08:23 AM EDT, 09/05/2025 (MT Newswires) -- Myers Industries ( MYE ) said Friday it appointed Samantha Rutty as chief financial officer, starting Sept. 22. Rutty will succeed Daniel Hoehn, who has been interim CFO since May 2 and will continue to work as vice president and corporate controller after the transition, the company said. Rutty will join Myers Industries...
Samsara Overcomes Q1 Tariff Woes, Poised for Growth on Deals Momentum, RBC Says; Shares Up Pre-Bell
Samsara Overcomes Q1 Tariff Woes, Poised for Growth on Deals Momentum, RBC Says; Shares Up Pre-Bell
Sep 5, 2025
08:21 AM EDT, 09/05/2025 (MT Newswires) -- Samsara (IOT) strong Q2 results show that the Internet-of-Things sensor developer has overcome Q1 tariff pressures and is poised for further growth, RBC said in a note to investors Thursday. The note described large deal momentum among six- and seven-figure customers, improving international business as well as its deal with Bonnie Plants, its...
Theratechnologies Launches New Tesamorelin Formulation in US After FDA Approval
Theratechnologies Launches New Tesamorelin Formulation in US After FDA Approval
Sep 5, 2025
08:23 AM EDT, 09/05/2025 (MT Newswires) -- Theratechnologies ( THTX ) said Friday its new tesamorelin formulation, Egrifta WR, is now available following Food and Drug Administration approval earlier this year. The drug is used to reduce excess abdominal fat in adult patients with HIV and lipodystrophy. The new version will gradually replace Egrifta SV. Egrifta WR requires weekly reconstitution...
BBVA Gets Approval for $20.3 Billion Banco Sabadell Takeover; Shareholders' Offer Opens Sept. 8
BBVA Gets Approval for $20.3 Billion Banco Sabadell Takeover; Shareholders' Offer Opens Sept. 8
Sep 5, 2025
08:25 AM EDT, 09/05/2025 (MT Newswires) -- Banco Bilbao Vizcaya Argentaria ( BBVA ) said Friday the Spanish National Securities Market Commission has approved its move to acquire Banco Sabadell in a deal valued at 17.40 billion Euros ($20.30 billion) and the take-up period is scheduled to begin on Sept. 8 for Banco Sabadell shareholders to accept its proposal. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved